Nuwellis (NUWE) Amortization of Deferred Charges (2023 - 2026)
Nuwellis' (NUWE) quarterly Amortization of Deferred Charges came in at $6.1 million in Q2 2026, down 42.41% on a YoY basis from $10.6 million in Q2 2025, and down 42.41% quarter-over-quarter from $10.6 million in Q2 2025.
Analysis
Nuwellis (NUWE) Amortization of Deferred Charges (2023 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Amortization of Deferred Charges for 4 consecutive years, with $6.1 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Amortization of Deferred Charges fell 42.41% year-over-year to $6.1 million; the trailing twelve-month figure through Jun 2026 stood at $16.6 million (up 2.91% YoY), and the FY2025 full-year result was $10.6 million, up 88.21% from the prior year.
- Amortization of Deferred Charges slipped to $6.1 million in Q2 2026 per NUWE's latest filing, from $10.6 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $10.6 million in Q2 2025 and bottomed at $3.5 million in Q4 2023.
- Historically, Amortization of Deferred Charges has averaged $6.4 million across 4 years, with a median of $5.8 million in 2024.
- The sharpest annual moves came in 2025 and 2026: Amortization of Deferred Charges jumped 88.21% in 2025, then sank 42.41% in 2026.
- Over 4 years, Amortization of Deferred Charges stood at $3.5 million in 2023, then surged by 60.98% to $5.6 million in 2024, then soared by 88.21% to $10.6 million in 2025, then tumbled by 42.41% to $6.1 million in 2026.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $6.1 million, $10.6 million, and $5.6 million for Q2 2026, Q2 2025, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.08 Mn |
| Jun 30, 2025 | 10.55 Mn |
| Jun 30, 2024 | 5.61 Mn |
| Dec 31, 2023 | 3.48 Mn |